Medtronic plc. ($MDT) Stock Forecast: Up 5.1% Today

What is Medtronic plc.?

Medtronic operates as a medical technology, services, and solutions company, aiming to improve patients' well-being through innovative medical devices and therapies.

Why is Medtronic plc. going up?

MDT stock is up 5.1% on Nov 18, 2025 17:55

• Following its Q2 earnings, Medtronic (MDT) saw a strong upward trend in its stock value, buoyed by exceeding earnings expectations and showcasing robust growth in the Cardiovascular segment.
• The company's revised 2026 outlook also bolstered investors' confidence, leading to a rise in the stock price.
• Analysts' positive forecast adjustments prior to the earnings announcement foreshadowed a strong performance, paving the way for the stock's climb post-earnings.
• Market response indicates investor trust in Medtronic's financial stability and growth opportunities, driving the stock's ascent as optimism for future success grows.

MDT Price Chart

MDT Technical Analysis

MDT News

Medtronic's Q2 Earnings & Revenues Beat Estimates, Stock Climbs

MDT posts Q2 earnings and revenue beat, powered by strong Cardiovascular growth and a raised 2026 outlook that lifts its shares.

https://www.zacks.com/stock/news/2792428/medtronics-q2-earnings-revenues-beat-estimates-stock-climbs

Medtronic ( MDT ) Q2 Earnings and Revenues Top Estimates

Medtronic (MDT) delivered earnings and revenue surprises of +3.82% and +1.11%, respectively, for the quarter ended October 2025. Do the numbers hold clues to what lies ahead for the stock?

https://www.zacks.com/stock/news/2792301/medtronic-mdt-q2-earnings-and-revenues-top-estimates

Top Wall Street Forecasters Revamp Medtronic Expectations Ahead Of Q2 Earnings - Medtronic ( NYSE:MDT )

Medtronic plc ( NYSE:MDT ) will release earnings results for the second quarter, before the opening bell on Tuesday, Nov. 18. Analysts expect the Galway, Ireland-based company to report quarterly earnings of $1.31 per share, up from $1.26 per share in the year-ago period.

https://www.benzinga.com/analyst-stock-ratings/price-target/25/11/48917113/top-wall-street-forecasters-revamp-medtronic-expectations-ahead-of-q2-earnings

Home Depot, Medtronic And 3 Stocks To Watch Heading Into Tuesday - AECOM ( NYSE:ACM )

With U.S. stock futures trading lower this morning on Tuesday, some of the stocks that may grab investor focus today are as follows: Wall Street expects Home Depot Inc. ( NYSE:HD ) to report quarterly earnings at $3.85 per share on revenue of $41.14 billion before the opening bell, according to ...

https://www.benzinga.com/markets/equities/25/11/48916350/home-depot-medtronic-and-3-stocks-to-watch-heading-into-tuesday

Stay Ahead of the Game With Medtronic ( MDT ) Q2 Earnings: Wall Street's Insights on Key Metrics

Beyond analysts' top-and-bottom-line estimates for Medtronic (MDT), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended October 2025.

https://www.zacks.com/stock/news/2790485/stay-ahead-of-the-game-with-medtronic-mdt-q2-earnings-wall-streets-insights-on-key-metrics

Trending Today

PancakeSwap ($CAKE) Crypto Forecast: Down 5.7% Today

Filecoin ($FIL) Crypto Forecast: Up 5.0% Today

Silver ($XAG) Commodity Forecast: Up 5.0% Today

Beyond Meat Inc. ($BYND) Stock Forecast: Up 5.7% Today

Comcast Corporation Class A Common Stock ($CMCSA) Stock Forecast: Up 5.0% Today

National Oilwell Varco Inc. ($NOV) Stock Forecast: Down 5.1% Today

Phillips 66 ($PSX) Stock Forecast: Down 5.1% Today

Pfizer Inc. ($PFE) Stock Forecast: Down 5.1% Today

Humana Inc. ($HUM) Stock Forecast: Down 5.1% Today

Cytokinetics, Incorporated ($CYTK) Stock Forecast: Down 5.0% Today

Medtronic plc. Price History

04.03.2025 - MDT Stock was down 5.5%

• MDT's stock (MDT) saw a -1.09% decrease, signifying a bearish trend.
• The decline in MDT's stock price may be linked to investors taking profits following a recent uptick.
• Concerns over potential regulatory changes in the healthcare sector could be making investors cautious, resulting in the drop in MDT's stock.
• This bearish movement in MDT's stock is likely a brief correction in response to market conditions rather than an indication of the company's underlying performance.

14.00.2025 - MDT Stock was up 5.2%

• Medtronic experienced a bullish movement, potentially influenced by positive analyst coverage and forecasts for Anteris Technologies, a player in the transcatheter valve replacement market.
• Analysts' positive outlook on Anteris Technologies' DurAVR valve system, expected to gain a significant market share by 2030, likely bolstered investor confidence in the broader medical technology sector.
• The encouragement of innovative technologies in healthcare may have positively impacted Medtronic, leading to an increase in its stock price.
• The optimistic view on advancements in transcatheter valve replacement technologies could be a contributing factor to Medtronic's overall bullish stock performance.

20.07.2025 - MDT Stock was up 5.3%

• Medtronic is a multinational medical technology company headquartered in Ireland, known for developing and manufacturing medical devices and equipment.
• The company reported strong Q1 earnings and revenue beats, along with an increased full-year EPS outlook, despite a slight decline in stock price.
• Q1 sales, adjusted EPS, and FY26 sales guidance all surpassed estimates.
• Analysts revised their forecasts ahead of the earnings call, expecting positive results for the company.
• The stock's positive movement today reflects the impact of the encouraging earnings report and raised sales guidance, even amid a minor drop in stock price.

23.09.2025 - MDT Stock was down 3.2%

• Medtronic (MDT) experienced a bearish movement today.
• The market might have reacted negatively due to potential concerns about the company's financial performance or future growth prospects.
• The news about businesses using Giftbit for rewards may not have directly impacted Medtronic's stock price, leading investors to focus on other factors affecting the company.
• Investors may be reevaluating their positions in Medtronic based on broader market trends or specific industry developments.

20.01.2024 - MDT Stock was up 2.7%

• Medtronic reported a 5% increase in revenue for Q3 2024, showcasing strong performance in its core business segments.
• The decision to exit unprofitable ventilator product lines and focus on high-demand areas like diabetes and cardiac rhythm management has boosted investor confidence.
• The company's adjusted earnings exceeding consensus estimates and raising full-year outlook has further contributed to the bullish market movement.
• The positive earnings and revenue surprises have likely driven investor optimism and propelled the stock price higher.

18.10.2025 - MDT Stock was up 5.1%

• Following its Q2 earnings, Medtronic (MDT) saw a strong upward trend in its stock value, buoyed by exceeding earnings expectations and showcasing robust growth in the Cardiovascular segment.
• The company's revised 2026 outlook also bolstered investors' confidence, leading to a rise in the stock price.
• Analysts' positive forecast adjustments prior to the earnings announcement foreshadowed a strong performance, paving the way for the stock's climb post-earnings.
• Market response indicates investor trust in Medtronic's financial stability and growth opportunities, driving the stock's ascent as optimism for future success grows.

18.10.2025 - MDT Stock was up 6.0%

• Medtronic (MDT) surpassed earnings and revenue forecasts for the second quarter, demonstrating strong financial results.
• Analysts raised their projections before the earnings announcement, indicating confidence in the company's expansion opportunities.
• The optimistic projections for Medtronic's Cardiovascular unit and Diabetes segment potentially influenced the stock's upward movement, highlighting potential growth in these key sectors.
• Overall, investors reacted favorably to Medtronic's robust performance and promising future prospects, leading the stock to climb higher.

21.04.2025 - MDT Stock was down 2.5%

• The stock declined despite surpassing Q4 forecasts and revealing plans to spin off its Diabetes business.
• The market's reaction could be attributed to profit-taking following recent positive developments, leading to a temporary downward trend.
• Investors may be exercising caution concerning the potential implications of the spinoff on Medtronic's operational efficiency and future growth opportunities.
• The stock's drop might also be influenced by broader market conditions or sector-specific factors impacting investor sentiment towards healthcare companies.

17.06.2024 - MDT Stock was up 3.6%

• Forecasts suggest a promising future for the Medical Technology Platform Market, with frontrunners like Medtronic driving innovation. This optimistic projection likely influenced the bullish trend in MDT stock.
• Medtronic's outperformance in market returns reflects investors' trust in the company's capabilities and growth prospects, boosting its stock value.
• The award bestowed upon Medtronic for its commitment to disability inclusion underscores its dedication to diversity and advancement, resonating positively with investors and buoying the stock price.
• In a quest for high-yield dividend opportunities to offset inflation, Medtronic's reliability and growth potential have piqued investors' interest, further fueling the bullish momentum in the stock.

17.06.2024 - MDT Stock was up 3.9%

• Medtronic's bullish movement could be attributed to being a high-yield dividend stock beating inflation, attracting investors looking to counter the effects of rising prices.
• The focus on undervalued healthcare stocks in the market could have positively impacted Medtronic's stock as investors seek opportunities in this sector.
• The integration of AI in healthcare for better patient outcomes could also have contributed to the positive sentiment around healthcare stocks, including Medtronic.
• The search for undervalued breakout stocks in the market may have led investors to discover the potential in companies like Medtronic, driving the bullish movement.

22.04.2025 - MDT Stock was down 5.8%

• Despite delivering strong fourth-quarter fiscal 2025 results with improvements in margins, Medtronic's stock experienced a bearish movement.
• The decision to spin off its Diabetes business into a standalone company could have initially raised concerns among investors about the potential impact on overall performance.
• The beat in Q4 earnings and revenue estimates might not have been substantial enough to offset broader market sentiment or concerns about the upcoming restructuring.
• Investor optimism about Medtronic's strength in the Cardiovascular portfolio may have been overshadowed by uncertainties surrounding the strategic shift in the company's business structure.

01.09.2025 - MDT Stock was down 2.3%

• Medtronic's stock price saw a 1.5% decrease amidst overall market pessimism.
• The larger decline in Medtronic's stock compared to the market suggests company-specific influences.
• Potential factors contributing to the bearish trend may involve earnings discrepancies, regulatory hurdles, or adverse developments impacting investor trust in the company's outlook.